GlaxoSmithKline collaborates with Harvard University on stem cell research

Monday 28 July 2008

Four days after announcing its first ever research agreement with the University of Cambridge in the UK, GlaxoSmithKline has disclosed a five-year collaboration with the Harvard Stem Cell Institute in the US to discover new therapies based on stem cell science.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom